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CASE REPORTS
The general trend today is toward minimally inva-
sive and traumatic surgical procedures. Endovascular
prostheses for repair of abdominal aortic aneurysm
have only recently been adopted for clinical use.1,2
This new method is especially suitable for patients
with aneurysms who are at high surgical risk and who
fulfill the technical requirements for insertion of the
endoluminal stent graft. The use of these prostheses,
however, may involve increased risk of infection, as
occurred in a patient who had endovascular abdomi-
nal aortic prosthetic graft infection as a result of
Listeria monocytogenes.
CASE REPORT
A 77-year-old man who was obese and hypertensive
was admitted for abdominal pain caused by a type B
abdominal infrarenal aortic aneurysm, which had a maxi-
mum transverse diameter of 6.6 cm and a neck longer than
20 mm.2 No signs indicating infective nature of the
aneurysm were present in the spiral computed tomo-
graphic (CT) scan. A bifurcated stent graft (Vanguard
26/12/153, Meadox, Oakland, NJ) was implanted with
limbs that terminated in the common iliac arteries, and an
additional short stent graft (Passager 12/60, Meadox) was
necessary to control leakage in the distal left limb of the
graft. The procedure was performed in the operating the-
ater. A dose of 1.5 g of cefuroxime and 1 g of vancomycin
hydrochloride was administered as antibiotic prophylaxis.
A moderate postimplantation syndrome with fever
developed without leukocytosis and with marked elevation
of C-reactive protein (CRP) concentration (range, 19 to
92 mg/L), which lasted for several days. Five days later, a
control duplex scan examination showed neither leakage
nor expansion of the aneurysmal sac and the patient was
discharged. Two months later, he was doing well and the
spiral CT scan results were unremarkable. Twelve weeks
after implantation, the patient was admitted for sepsis with
a temperature of 40°C. His general condition was poor,
and he had low back and abdominal pains that radiated to
the inguinal regions. Laboratory test results showed an
elevated white blood cell count and a marked increase in
CRP level (165 mg/L). At this stage, the CT scan
revealed only a thrombosed aneurysmal sac around the
endovascular stent graft, with no intensification with con-
trast liquid and nothing specific about the graft infection.
Antibiotic treatment was begun with vancomycin
hydrochloride (500 mg, four times daily) and imipenem
(1 g, three times daily). The blood cultures were sterile.
To exclude acute appendicitis, an appendectomy was per-
formed through the transverse incision because of the
lower abdominal pain, fever, and high CRP level. The
appendix was not inflamed, and no intra-abdominal focus
was observed.
A scan with indium-labeled leukocytes showed a focus
of increased activity corresponding to the region of the
infrarenal abdominal aorta. Bacterial cultures taken from
the aneurysmal sac or perigraft space with fine needle
under ultrasound scan guidance yielded Listeria monocyto-
genes, which thus confirmed the infection of the endolu-
minal stent graft. Transesophageal echocardiography was
performed to rule out endocarditis-related infected
aneurysms but revealed no evidence of endocardial vege-
tation. The previously started antibiotic regimen was dis-
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continued and changed according to tests of antibiotic
resistance to ampicillin (2 g, six times daily) and netilmicin
(300 mg, once daily). Surgery was postponed to better
control the septicemia with antibiotics. Fourteen days
later, no proper response was achieved with appropriate
antibiotics alone—the patient was febrile and the CPR
level remained between 150 and 200 mg/L. The decision
for laparotomy and surgical strategy was planned in
advance when the negative blood cultures and low viru-
lence of the organism were considered.
At laparotomy (ie, 2 weeks after appendectomy),
inflammation surrounded the aneurysmal wall and iliac
arteries. The left iliac artery was thicker than the right
artery. An abscess that contained a clear, green fluid was
found adjacent to the aortic bifurcation between the
aneurysm and vena cava, with no evidence of past or
recent aortic or bowel perforation. The iliac arteries were
clamped and cut below the limbs of the stent graft. The
aneurysm and the iliac arteries with the prosthesis inside
were then resected en bloc, upward from below without
incising the aneurysm (Fig 1). The aorta was not closed
until the resection reached the renal artery level. After the
careful debridement of infected tissue, the operative field
was irrigated with ampicillin solution. The aneurysmal sac
that was removed was filled with infected thrombus. The
aortoiliac continuity was restored with an in situ poly-
tetrafluoroethylene (PTFE) bifurcation vascular prosthesis
that was wrapped carefully in retroperitoneal and omental
tissues. The right limb was anastomosed to the right com-
mon iliac artery, and the left limb to the left external iliac
artery. The contents of the sac and samples of the endolu-
minal graft were cultured. All the culture results were neg-
ative, probably because of the effective antimicrobic ther-
apy administered.
After surgery, netilmicin was discontinued and the
course of antibiotics was continued intravenously for 6
weeks with ampicillin.3,4 Recovery was uneventful, exclud-
ing several episodes of diarrhea. The patient remained
afebrile, and CRP concentration decreased from the pre-
operative level to 20 mg/L in 10 days. A new scan with
indium-labeled leukocytes that was performed 3 weeks
after laparotomy revealed no activity at the operative site.
At discharge, the CRP level was 11 mg/L. Antibiotic pro-
phylaxis was continued orally with doxycycline (150 mg,
once daily) for 4 weeks. At the 3-month and 10-month
follow-up examinations after aortoiliac reconstruction,
there was no evidence of recurrent infection or peripros-
thetic problems. The patient was afebrile, the latest eryth-
rocyte sedimentation rate was 4 mm/h, and the CRP level
was less than 5 mg/L.
DISCUSSION
Listeria monocytogenes is a small, facultatively
anaerobic, gram-positive bacillus commonly found in
soil, decaying vegetation, and fecal flora of several
mammals.3,5,6 The infection probably begins after the
ingestion of contaminated foods. The bacterium
crosses the mucosal barrier of the intestine, passes into
the bloodstream, and may disseminate hematoge-
nously. Microbiologically, the infecting organism
from the samples was confirmed with typical colony
morphology and was gram-positive, catalase-positive,
and esculin-positive, and the reactions were typical for
Listeria monocytogenes with a commercial biochemical
kit (Rosco Diagnostica, Taastrup, Denmark).
One could suspect that the patient had a mycotic
or infected aneurysm before the stent graft was
implanted because listerial bacteremia can lead to the
development of arteritis or endocarditis. However,
there were no signs of either silent bacteremia or infec-
tive nature of the aneurysm. Preoperative laboratory
study results were unremarkable, and no clinical 
manifestations of central nervous system infection, 
the most common target of Listeria monocytogenes
infection, were observed.3,4 Later, transesophageal
echocardiography was performed after positive bacter-
ial cultures to rule out endocarditis-related aneurysm.
The echocardiogram revealed no evidence of endocar-
dial vegetation. The likelihood that the patient previ-
ously had mycotic or infected aneurysm and that the
endovascular graft was implanted in a contaminated
field was only theoretic.
Few reports are available of arterial or prosthetic
graft infections caused by Listeria monocytogenes.7,8
Because Listeria monocytogenes is an inhabitant of the
bowel flora, iatrogenic insidious bowel complication
during intrumentation of stent graft implantation
may be considered as a possible portal of entry. The
possibility cannot be eliminated, although no evi-
dence of gastrointestinal tract complications could be
found at laparotomy. However, we consider that the
probable cause might be better explained by late
hematogenous spreading of the microbe from the
gastrointestinal tract after the patient had already
been discharged.
Fig 1. Abdominal aortic aneurysm resected en bloc with
infected bifurcated endoluminal stent graft.
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The new endovascular stent grafting technique
normally leaves the aneurysmal content intact as com-
pared with standard aneurysm surgery. However, the
aortic endothelium may be damaged during peripro-
cedural instrumentation, which makes contamination
possible in cases of infected aneurysmal content or
thrombus. Routine bacterial culture of the intra-
aneurysmal thrombus is hardly possible, and further-
more, the value of culturing aneurysmal contents in
predicting subsequent sepsis is controversial. In par-
ticular cases, a scan with indium-labeled leukocytes
may be feasible to screen subclinical mycotic or infect-
ed aneurysm before endoluminal grafting procedures.
Endovascular exclusion of aortic aneurysm has been
proven clinically effective, but the related morbidity,
including infections, remains to be seen. To date, the
complications published have been embolic or related
to the intervention.2,9
The outcome of untreated aortic graft infections
or those treated exclusively with antibiotics is invari-
ably fatal. Successful results require a combination of
systemic antimicrobic administration and surgery.
The principle of surgical treatment is the total exci-
sion of the infected graft. Early diagnosis and timely
surgery enhance the possibility of survival. When
presented with the problem, we reasoned that radi-
cal resection of the infected stent graft with the
aneurysm, debridement of all infected tissue, in situ
aortoiliac grafting with PTFE prosthesis, and ade-
quate postoperative antibiotic therapy would eradi-
cate the infection. The PTFE graft was preferred as
aortoiliac prosthetic material because of minor
adherence of bacteria to the PTFE fabric.
It is unclear whether single-stage in situ aortic
repair should be performed in an infected field. The
first choice after the removal of all infected tissue
without performing vascular repair is to carefully
observe the circulation to the feet and, if necessary,
perform subsequent repair (eg, through the extra-
anatomic route). The other available options for
restoration of arterial continuity to the lower
extremities after graft removal are the single-stage
procedure described here, the use of homografts or
superficial femoral veins, or the performance of a
prosthetic axillobifemoral bypass grafting procedure.
The patency rate of axillobifemoral grafting, howev-
er, is clearly inferior as compared with grafting by
means of the anatomical route. On the other hand,
the risk of infection of any prosthetic material should
be considered in the presence of bacteremia, and
prolonged or even permanent antibiotic therapy
should be relied on for its prevention. No cases have
been published of surgical management in the event
of prosthetic infection with Listeria monocytogenes as
we described. We believe it was justified in an aged
patient to perform prosthetic in situ grafting as we
did. However, the type of reconstruction in the sit-
uation we detailed must be individualized. Should
infection of the new graft occur, it would be possi-
ble to remove the prosthesis and plan a secondary
reconstruction (eg, via the axillobifemoral route). In
this case, we reported that in situ grafting was suc-
cessful at the 10-month follow-up examination.
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